Joachim Auerbach Selected Research

glyceryl methyl methacrylate

6/2022	Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
4/2022	GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joachim Auerbach Research Topics

Disease

3	Neutropenia 06/2022 - 03/2022
3	Bacillary Dysentery (Shigellosis) 04/2022 - 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Tetanus 01/2017
1	Diphtheria 01/2017

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 06/2022 - 01/2017
2	glyceryl methyl methacrylateIBA 06/2022 - 04/2022
1	AntibodiesIBA 09/2021
1	Immunoglobulin G (IgG)IBA 09/2021
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	O Antigens (O Antigen)IBA 01/2017
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 01/2017
1	AntigensIBA 01/2017
1	Pertussis VaccineIBA 01/2017